Articles On Telix Pharmaceuticals (ASX:TLX)

04 Apr 2022 - A snapshot of the stocks on the move featuring Pepper Money (ASX:PPM), Telix Pharmaceuticals (ASX:TLX) & Iluka Resources (ASX:ILU).

MELBOURNE, Australia, April 4, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) Project, which has been aw...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. Good news for coffee lovers, particularly those w...

Non-Executive Director Oliver Buck to retire at the Annual General Meeting Tiffany Olson, experienced U.S.-based pharma executive appointed as independent Non-Executive Director MELBOURNE, Australia and INDIANAPOLIS, March 31, 2022 /...

MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the launch of PSMA PET/CT[1] Today, a five-part video series, featuring leading theranostic...

Highlights The ASX 200 closed higher today, gaining 51.90 points or 0.70% to 7,464.30. Wall Street's gains overnight and revived hopes for fresh cease-fire talks between Russia and Ukraine seem to be lifting investor sentiment. In Aus...

The S&P/ASX Emerging Companies (XEC) Index is racking about 0.3% higher on Tuesday, while the benchmark ASX 200 (XJO) rose 0.7%, buoyed by a resurgent tech sector and a strong performance from consumer discretionary companies ahead of t...

MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designati...

ASX 200 notched up sixth day of gains Retailers, tech were best performing sectors Fed Budget to be delivered at 7.30pm AEDT tonight Retailers, Tech lead the way Local shares head into tonight’s Federal Budget in flying colours after clo...

The share market closed at a ten-week high as blue-chip healthcare, banking and consumer stocks took the lead during a pause in a two-week commodities rally.   The S&P/ASX 200 climbed 52 points or 0.7 per cent to its strongest close...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.7% to 7,467.2 points. Four ASX shares that are climbing more than most today are listed below...

Tech stocks took up the running as the Australian share market rose for a sixth session ahead of tonight’s Federal Budget. The S&P/ASX 200 climbed 59 points or 0.8 per cent to its highest since mid-January. The I.T. sector jumped...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is heading north during late morning trade following a company announcement. At the time of writing, the biotechnology company’s shares are selling for $4.56 apiece, up 9.88%. What did...

MELBOURNE, Australia and LIÈGE, Belgium, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Xiel Limited (Xiel) for the distribution of Telix’...

The Australian market remains resilient to the threat of higher energy prices with the S&P/ASX 200 (ASX: XJO) gaining another 0.3% to finish the week. The result was driven by a rally in the energy, materials and utilities sectors, whic...

The share market sealed back-to-back weekly gains with a fourth straight advance after strong economic data and a pause in energy prices lifted Wall Street. The S&P/ASX 200 climbed 19 points or 0.26 per cent. The rally lifted the ben...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a high. At the time of writing, the benchmark index is currently up 0.4% to 7,414.6 points. Four ASX shares that have failed to follow the market h...

A rebound on Wall Street helped propel the ASX towards a fourth straight gain as a two-week mining rally rolled on. The S&P/ASX 200 climbed 38 points or 0.52 per cent by mid-session. The rally lifted the benchmark above 7400 for the...

With interest rates almost guaranteed to head upwards this year, multiple experts are emphasising profitability, or at least positive cash flow, as essential for investment. “As interest rates rise, if you don’t have any profit or cash fl...

Australian shares inched to a fresh nine-week high as strengthening commodity prices helped the market weather overseas weakness ahead of tonight’s meeting of US and European leaders. Miners and oil producers advanced as the S&P/ASX...

MELBOURNE, Australia, March 23, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces it has made significant progress in advancing the Company’s glioblastoma multiforme (GBM) therapy candidate TLX101 in...

The share market rallied to a two-month closing high, bolstered by rising commodity prices and the prospect of record-low rates for some time to come. Strong gains in BHP, Rio Tinto and Newcrest helped lift the S&P/ASX 200 63 points...

Telix Pharmaceuticals (TLX) provides an update regarding the development of its radiopharmaceutical production facility in Belgium The facility will serve as the primary European manufacturing site for Telix’s products and will play an imp...

Australia’s strength in natural resources fired the share market to a two-month high despite declines on Wall Street as investors fretted about soaring inflation. The S&P/ASX 200 surged 89 points or 1.22 per cent to 7367 by mid-sessi...

Highlights The benchmark ASX 200 was up 0.76% to 7,347.7 in the first 15 minutes of trading. US stocks took a U-turn on Monday, after rallying for four straight sessions. The energy and materials sectors were roaring today with gains...

22 Mar 2022 - A snapshot of the stocks on the move featuring New Hope (ASX:NHC), Telix Pharmaceuticals (ASX:TLX) & Bubs Australia (ASX:BUB).

A third day of gains lifted the share market to its highest close in a month as a rebound in commodity prices boosted mining and energy companies. The S&P/ASX 200 rallied 44 points or 0.6 per cent to 7294. The index closed less than...

Telix (ASX:TLX) has announced that its ZIRCON Phase 3 study of investigational kidney cancer imaging agent, TLX250-CDx, has dosed the target enrolment of 252 patients.

The S&P/ASX 200 (ASX: XJO) delivered another positive day despite the incredibly negative backdrop with issues ranging from inflation to commodity price uncertainty and the Ukraine invasion. The market finished 1% higher with the techno...

Today, the S&P/ASX 200 Index (ASX: XJO) reclaimed the 7,000 point level, bucking the trend set on Wall Street last night. At the end of the session, the benchmark index finished 1.04% higher at 7,053 points. Aussie shares broke throug...

The Mesoblast Limited (ASX: MSB) share price has been regaining some of its recent losses today. In afternoon trade, shares in the regenerative medicines company are fetching $1.20, up 16.5%. Despite the gain, shareholders are still a dis...

Telix Pharmaceuticals (TLX) completes target enrolment for its phase III ZIRCON study in patients with kidney cancer A total of 252 patients have now been dosed with TLX250-CDx with the aim of the study to determine the sensitivity and spe...

The ASX 200 Health Index (XHJ) is trading higher by 1.90% at the time of writing, compared to the broader index which is down by 0.30%. Oncology specialist Telix Pharmaceuticals (ASX: TLX) announced that its ZIRCON Phase 3 kidney cancer stu...

08 Mar 2022 - A snapshot of the stocks on the move, featuring Home Consortium (ASX:HMC), Telix Pharmaceuticals (ASX:TLX) & Calix (ASX:CXL).

SYDNEY, March 3, 2022 /PRNewswire/ — Boutique investment and advisory firm Magnolia Capital has released its CY 2021 data that confirms its Magnolia Capital Emerging Companies Microcap Fund 1 ("the Fund") was the highest-performing microcap...

President Biden delivered his annual State of the Union address during the session, with strong commentary around Ukraine and targeted investment into domestic manufacturing capacity supporting US futures and ultimately pushing the S&P/...

Highlights  The ASX 200 closed 0.3% higher, up 20.2 points to 7116.7 with most sectors lower aside from mining and energy stocks. Geopolitical tensions escalated as Russia further advanced its invasion of Ukraine. Crude oil prices sur...

The major miners dug the share market out of a hole after soaring commodity prices helped drive Wall Street sharply lower overnight. The S&P/ASX 200 fell 55 points in early action before a commodities-led rebound. The Australian benc...

02 Mar 2022 - A snapshot of the stocks on the move featuring Mineral Resources (ASX:MIN), Transurban (ASX:TCL) & Telix Pharmaceuticals (ASX:TLX).

Australia’s status as a commodities world-leader helped shield it from pressure on financial markets as surging commodity prices sharpened inflationary worries. Gains in miners and oil producers helped the S&P/ASX 200 advance 16 poin...

Highlights The benchmark ASX 200 index fell 0.68% to 7,047 in the first 15 minutes of morning trade. Brent crude oil surged past US$107 per barrel on Tuesday. The market is having a bearish tilt today with nine out of the 11 sectors t...

Today, the S&P/ASX 200 Index (ASX: XJO) avoided negative territory after its worst fall in 17 months yesterday. At the end of the session, the benchmark index finished 0.1% higher at 6,997.8 points. Investors were torn in two directio...

The share market closed out its worst week since 2020 with a modest rebound as fighting in Ukraine and weak US futures capped risk appetite. An early relief rally mostly petered out as investors awaited evidence the worst of the Ukraine...

A massive overnight reversal on Wall Street and a strong trading update from Afterpay’s US parent company helped the share market pare its losses for the week. The S&P/ASX 200 rallied 16 points or 0.23 per cent as bargain-hunters too...

The share market tumbled 3 per cent to its heaviest loss of the year after Russian troops attacked Ukraine. Oil and gold spiked after explosions were reported in major Ukrainian cities, including the capital, Kiev. Dow futures slumped 62...

The share market slumped 2.5 per cent towards its second-heaviest loss of the year after the Dow closed on the edge of a correction overnight. The S&P/ASX 200 dived 182 points or 2.52 per cent by mid-session. A final loss on that sca...

ShareCafeBuying Opportunities Beckon Amid Biotech Bloodbath The sharp retreat in global biotech valuations is creating rare buying opportunities as investors flee ‘riskier’ sectors on the back of rising interest rates, dwindling liquidity a...

Seven more capital raises were announced today, adding to the 89 ASX-listed companies that have raised almost $2 billion so far this year — that’s an average raise of $22 million. By far, the largest capital raise of 2022 to date was the...

Telix (ASX:TLX) had announced a commercial distribution agreement with Global Medical Solutions Australia for its prostate cancer imaging product Illuccix in the Australian market.

Telix Pharmaceuticals (TLX) enters into an agreement for the commercial distribution of its prostate cancer imaging product Illuccix in Australia The agreement with Global Medical Solutions Australia (GMSA) will see Telix’s product become...